Sequential high-dose cytosine arabinoside and asparaginase in refractory acute leukemia
Open Access
- 1 January 1982
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 10 (S1) , 221-228
- https://doi.org/10.1002/mpo.2950100722
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- High dose cytosine arabinoside (HDARAC) in refractory acute leukemiaCancer, 1979
- Advances in the Treatment of Acute Myelogenous LeukemiaNew England Journal of Medicine, 1979
- Toxicity of combinations of arabinosylcytosine and 3-deazauridine toward neoplastic cells in cultureBiochemical Pharmacology, 1978
- Inhibition of intracellular pyrimidine ribonucleotide reduction by deoxycytidine, arabinosylcytosine and hydroxyureaBiochemical Pharmacology, 1976
- Deoxycytidine kinase: properties of the enzyme from human leukemic granulocytesBlood, 1975
- Mechanisms of Resistance of Human Acute Leukaemia Cells to Cytosine ArabinosideBritish Journal of Haematology, 1974
- Clinical pharmacology of l‐β‐D‐arabinofuranosyl cytosineClinical Pharmacology & Therapeutics, 1971
- Eclipsing Binary Model of Cygnus XR-1Nature, 1971
- Studies on a new mechanism of resistance of L5178Y murine leukemia cells to cytosine arabinosideBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1968
- Transport and Phosphorylation as Factors in the Antitumor Action of Cytosine ArabinosideScience, 1967